BR Pharm Co., Ltd., is specilized in the PDRN
for the advancement of Regenerative Medicine and Aesthetic Medicine
Company Introduction
Biopharmaceutical company specialized in Regenerative medicine
BR Pharm is a biopharmaceutical company specializing in regenerative medicine.
We are striving to improve the health and quality of life of humans and animals by studying musculoskeletal disease based on PDRN materials by using natural resources.
We will continue to challenge the wide range of development and research to enable everyone to live in a beautiful and pleasant life.
Medicine
Under progressing competitive products development through local license(KFDA) for PDRN-based Active Pharmaceutical Ingredient(API), Sterile injection, joint filler
Medical Device
Product development for aesthetic & medical purpose filler, Skin Regeneration, and Lipolysis product by PDRN and PN ingredient
Cosmeceuticals
Over 10 years in the cosmetics business to provide products to more than 3,500 clinics
Food
Food production business using sea trout
Food production business using sea trout
| The 1st Factory
| The 2nd Factory
Industrial complex, Wonju-si, Gangwon-do, Korea
| The 3th Factory (Raw material medicine business area)
Geumsan-myeon, Goheung-gun, Jeollanam-do, Korea
![DJI_0026[(002013)2018-07-13-11-03-39].JP](https://static.wixstatic.com/media/9d23bc_5a3ec8eb1dde4d5eb61a63976661bb97~mv2.jpg/v1/fill/w_238,h_131,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/DJI_0026%5B(002013)2018-07-13-11-03-39%5D_JP.jpg)
| Research institute
| Marketing & Sales Dept.
Munjeong-dong, Songpa-gu, Seoul, Korea
| China Shanghai BR Pharm branch office
Headquarters
-
BR Pharm Co., Ltd.
-
Established in July 2005
-
Business areas : Cosmeceutical and cosmeceutical raw material medicines
development & production
-
AUTOMATIC SYSTEM
-
Secure productivity by automated system
-
GMP, BGMP, CE, ISO13485/22716/9001
FILLING & SEALING MACHINE
PREFILLED SYRINGE
BRPHARM raw material medicine
-
Geumsan-myeon, Goheung-gun, Jeollanam-do, Korea
-
Area 14,280 ㎡
-
13.4 billion won investment facility
-
To sign MOU with Korea government institution of Jeollanam-do Institution of Ocean & Fisheries Technology
-
Production of PDRN raw material medicines through clean seawater in South sea
-
Hazard Analysis and Critical Control Point Management Facility (HACCP certified)
-
ISO 9001:2015
Raw materials business (Farm) System
Farm seawater circulation filtration system
Sea pump
High Tank / Sand filtration
Sediment filtration /
Fresh water & Sea water tank
Septic tank
(Circulation filtration system)
Sea trout farm
using clean seawater in South sea
Seawater storage and sand sediment and filter function
Seawater sludge and sediment filtration
Purified freshwater and seawater storage
Remove foreign material with drum filter
Eliminate hazardous substances with EM supply
Energy conservation and eco-friendly farming method
Circulation filtration system
With the heat pump operation, Water Quality is managed by the circulation filtration system.
The circulation filtration system uses a drum filter to remove solid foreign substance
Remove harmful substances dissolved in water by supplying Biofloc EM microbes.
Heat Pump
![MVI_1397[(001295)2019-01-30-09-52-39].JP](https://static.wixstatic.com/media/9d23bc_f284b8f964c145ee9a701d9f52070ec9~mv2.jpg/v1/fill/w_273,h_156,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/MVI_1397%5B(001295)2019-01-30-09-52-39%5D_JP.jpg)
Drum Filter
![C0012[(003736)2018-07-13-11-06-16].JPG](https://static.wixstatic.com/media/9d23bc_7ee270f1da0d43af97a0fb1c90078032~mv2.jpg/v1/fill/w_274,h_156,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/C0012%5B(003736)2018-07-13-11-06-16%5D_JPG.jpg)
Biofloc
BR PHARM Co.,Ltd. I Representative : Kim Seok Soon I Business License Neumber : 122-81-87742
Tel : +82-2-2148-6700 I Fax : +82-2-2148-6777 I E-mail :brpharm3@brpharm.com
Headquarters13, Sinpyeong-ro, Sinpyeong-ri, Jijeong-myeon, Wonju-si, Gangwon-do, Republic of Korea
Research institute644 Munjeong-dong, Songpa-gu, Seoul, Korea
Copyrigth © BR PHARM Co.,Ltd. all right reserved.
